KPWS
ALLO icon

Kestra Private Wealth Services’s Allogene Therapeutics ALLO Stock Holding History

Kestra Private Wealth Services’s Portfolio ALLO Stock Details ALLO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$26.6K Buy
+10,909
New +$21.9K ﹤0.01% 1732

Other funds holding ALLO

P
Pfizer New York $239M AUM 232.47% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
TGA
TPG GP A Fort Worth, Texas $3.68B AUM 14.99% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Kestra Private Wealth Services's ALLO Position: Q1 2026 in Review

Kestra Private Wealth Services opened a new position in Allogene Therapeutics (ALLO) in Q1 2026: 10,909 shares worth $26.6K. The stake represents ﹤0.01% of the portfolio and ranks #1732 among its holdings.

208 funds tracked by Wall St. Rank hold ALLO as of Q1 2026.

  • Kestra Private Wealth Services held 10,909 shares of Allogene Therapeutics worth $26.6K as of Q1 2026.
  • Allogene Therapeutics was a new Kestra Private Wealth Services position in Q1 2026.
  • Allogene Therapeutics made up ﹤0.01% of Kestra Private Wealth Services's portfolio in Q1 2026, its #1732 holding.
  • 208 funds tracked by Wall St. Rank held Allogene Therapeutics as of Q1 2026.

Based on Kestra Private Wealth Services's 13F filing for Q1 2026, filed 20 Apr 2026.